{"id":2077946,"date":"2023-10-24T15:27:01","date_gmt":"2023-10-24T19:27:01","guid":{"rendered":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/astrazeneca-asks-fda-to-sign-off-on-self-administered-flu-vaccine\/"},"modified":"2023-10-24T15:33:45","modified_gmt":"2023-10-24T19:33:45","slug":"astrazeneca-asks-fda-to-sign-off-on-self-administered-flu-vaccine","status":"publish","type":"post","link":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/astrazeneca-asks-fda-to-sign-off-on-self-administered-flu-vaccine\/","title":{"rendered":"AstraZeneca seeks FDA approval for self-administered flu vaccine."},"content":{"rendered":"<aside class=\"mashsb-container mashsb-main mashsb-stretched\"><div class=\"mashsb-box\"><div class=\"mashsb-count mash-medium\" style=\"&quot;\"><div class=\"counts mashsbcount\">16<\/div><span class=\"mashsb-sharetext\">SHARES<\/span><\/div><div class=\"mashsb-buttons\"><a class=\"mashicon-facebook mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.conservativenewsdaily.net%2Fbreaking-news%2Fastrazeneca-asks-fda-to-sign-off-on-self-administered-flu-vaccine%2F\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Facebook<\/span><\/a><a class=\"mashicon-twitter mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/twitter.com\/intent\/tweet?text=&amp;url=https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=2077946&amp;via=ConservNewsDly\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Twitter<\/span><\/a><a class=\"mashicon-subscribe mash-medium mash-nomargin mashsb-noshadow\" href=\"#\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Subscribe<\/span><\/a><div class=\"onoffswitch2 mash-medium mashsb-noshadow\" style=\"display:none\"><\/div><\/div>\n            <\/div>\n                <div style=\"clear:both\"><\/div><\/aside>\n            <!-- Share buttons by mashshare.net - Version: 4.0.47--><h2>AstraZeneca Seeks FDA\u2064 Approval for Needle-Free Nasal \u200dSpray Flu Vaccine<\/h2>\n<p>The British\u2063 pharmaceutical company AstraZeneca has submitted an application to the U.S. Food and Drug Administration (FDA) to market a \u200bgroundbreaking self-administered flu vaccine in the form of a needle-free nasal spray. This innovative product, called FluMist, has been a vital tool \u2064in public\u200c health for over two decades and is currently approved for individuals aged 2 to 49.<\/p>\n<h3>Revolutionizing Flu Vaccination<\/h3>\n<p>AstraZeneca&#8217;s Executive Vice President \u2063for Vaccines\u200b and Immune Therapies, Iskra Reic, expressed excitement about the potential of FluMist to revolutionize flu vaccination. If approved,\u2063 FluMist would become the first and \u2064only self-administered flu vaccine, offering\u200d a more accessible option for individuals,\u2062 families, and communities. \u2063AstraZeneca \u200benvisions a future where FluMist can be conveniently ordered and delivered directly to\u200b people&#8217;s homes.<\/p>\n<p>FluMist is currently \u200bthe only <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/no-more-shots-future-of-covid-vaccines-might-just-be-nasal-sprays-patches\/\" title=\"No More Shots? Future Of COVID Vaccines Might Just Be Nasal Sprays, Patches\">nasal spray vaccine<\/a> available and has demonstrated comparable efficacy to traditional \u200binjection \u2063vaccines for individuals under the age of \u206250, who are at lower risk of severe influenza illness. Since its initial approval in the United \u2064States in \u200d2003, over 200 million doses of FluMist have been sold worldwide.<\/p>\n<h3>Addressing Declining Vaccination\u2064 Rates<\/h3>\n<p>Influenza vaccination rates have been declining since the onset of the COVID-19 pandemic. \u200cCoverage for flu vaccines in adults over 18 has\u2063 decreased by 2.5 percentage points, while <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/pfizer-and-moderna-stocks-tumble-over-anticipated-low-covid-19-vaccination-rate\/\" title=\"Pfizer and Moderna stocks drop due to expected low COVID-19 vaccination rate.\">vaccination \u2064rates<\/a> for children between 6 months and 17 years have plateaued. Recognizing this concerning trend, Ravi Jhaveri, the Pediatric Infectious\u2064 Diseases division head at the Children&#8217;s Hospital of \u2064Chicago,\u200d emphasizes the need \u200dfor more accessible solutions to boost \u200bvaccination rates.<\/p>\n<p>AstraZeneca believes that if approved, FluMist could be administered by anyone over the age of 18 to \u2064patients within the \u2064appropriate age range. This flexibility in vaccine administration could \u200bsignificantly increase access and ultimately \u2063improve \u2063vaccination rates,\u200d according to Jhaveri.<\/p>\n<h3>Looking Ahead<\/h3>\n<p>The FDA is expected to make a decision regarding FluMist in the\u2062 first quarter \u2062of \u20622024. Meanwhile, the Centers for Disease Control and Prevention (CDC) estimates that between 9 million \u200band 41 million people in the United States fall ill with influenza each year. In the worst years, there \u200dare over 710,000 hospitalizations and 52,000 \u200bdeaths attributed to the flu. The direct costs associated with hospitalizations \u2064and outpatient visits for adults average around $10.4 billion.<\/p>\n<p>For \u200cmore information, <a href=\"https:\/\/www.washingtonexaminer.com\">click here to read more from The\u2064 Washington Examiner<\/a>.<\/p>\n<p> <\/p>\n<h2> How can\u200b the introduction of a\u200d self<a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/astrazeneca-asks-fda-to-sign-off-on-self-administered-flu-vaccine\/\" title=\"AstraZeneca seeks FDA approval for self-administered flu vaccine.\">-administered nasal spray flu \u200bvaccine address barriers<\/a> \u2064to vaccination, such as \u200bfear of needles or lack of \u200caccess to healthcare facilities<\/h2>\n<p><span>  Viduals who are afraid of needles or have difficulty receiving injections. This needle-free nasal spray flu vaccine would provide an alternative method of \u2063administration, making it easier for \u2063people to protect themselves and their communities \u200dfrom\u2062 the flu.<\/p>\n<p>FluMist works \u200bby delivering \u200ca weakened live virus\u200d through the nose, stimulating an immune response that helps the body develop \u200bresistance to \u2064the flu virus. This method of delivery has been proven to be effective in preventing flu infections and reducing the severity of symptoms in those who do get infected. It has been widely used in the United States for years and \u2062has\u200b a <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/russia-records-over-40000-coronavirus-cases-for-3rd-straight-day\/\" title=\"Russia Records over 40,000 Coronavirus Cases for 3rd Straight Day\">good safety profile<\/a>.<\/p>\n<p>According to the Centers for Disease Control and \u200cPrevention (CDC), \u2063flu vaccination is the best\u2062 way\u200c to prevent the flu and its\u2063 complications.\u200c However, the CDC also acknowledges that vaccination rates could be improved. The introduction \u200bof a self-administered nasal \u200dspray\u2063 flu vaccine\u200d could potentially address some of the barriers to vaccination,\u200d such as fear of needles\u2063 or access to \u2064healthcare facilities.<\/p>\n<p>In addition to its convenience, FluMist also has the potential to \u2062increase\u200c overall\u200d vaccination rates. Research has \u2064shown that people \u200care more likely\u200b to get \u200dvaccinated\u200d if the method of administration is more\u2063 convenient and\u2064 less painful.<\/p>\n<p>AstraZeneca&#8217;s application to the FDA is supported by clinical \u200cstudies\u200d that have\u200c demonstrated the safety and\u2063 efficacy of FluMist in preventing flu infections. The company is committed to working closely with the FDA to provide all necessary data\u200c and information for\u2062 a thorough evaluation.<\/p>\n<p>If approved, FluMist would offer a new, non-invasive option for flu\u2062 vaccination, potentially increasing the number\u2063 of people protected against the flu. \u2063This could have a significant impact on public health, reducing the \u2062burden on healthcare systems and\u200d preventing the spread of the virus.<\/p>\n<p>In conclusion, AstraZeneca&#8217;s application for FDA approval of the needle-free nasal spray flu vaccine, FluMist, represents a <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/democrat-controlled-house-passes-1-9-trillion-stimulus-bill-two-dems-vote-against-it\/\" title=\"Democrat-Controlled House Passes .9 Trillion Stimulus Bill; Two Dems Vote Against It\">significant step forward<\/a> in flu vaccination. If approved, this groundbreaking product has the \u2064potential\u2063 to revolutionize \u200cflu \u200dprevention \u200bby providing a convenient and\u200b accessible\u200c option\u2062 for individuals who are afraid of needles or have difficulty\u200b receiving injections. \u200dBy \u2062increasing overall vaccination rates, FluMist\u2062 could help to reduce \u200dthe burden of flu infections on individuals and healthcare \u200dsystems alike. The FDA&#8217;s evaluation of FluMist will\u2062 be eagerly awaited, as it has the potential \u2064to change \u2062the landscape of\u200c flu vaccination.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AstraZeneca seeks FDA approval for a needle-free nasal spray flu vaccine. Iskra Reic, EVP for Vaccines and Immune Therapies, stated that FluMist has been vital for public health.<\/p>\n","protected":false},"author":1,"featured_media":2077947,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","fifu_image_alt":"","footnotes":""},"categories":[538],"tags":[],"class_list":["post-2077946","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-washington-examiner"],"fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","_links":{"self":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2077946","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/comments?post=2077946"}],"version-history":[{"count":0,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2077946\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media\/2077947"}],"wp:attachment":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media?parent=2077946"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/categories?post=2077946"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/tags?post=2077946"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}